Outcomes in verteporfin photodynamic therapy for choroidal neovascularisation--'beyond the TAP study'.
D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D015350:Contrast Sensitivity; D005500:Follow-Up Studies; D006801:Humans; D008268:Macular Degeneration / Q000150:complications; D009216:Myopia / Q000150:complications; D010778:Photochemotherapy / Q000379:methods*; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D012008:Recurrence; D000077362:Verteporfin; D014792:Visual Acuity
D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin